Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-14 Purchase |
2024-02-15 4:21 pm |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
2,000 | $11 | $22,000 | 2,000 (Direct) |
View |
| 2024-01-24 Sale |
2024-01-24 5:27 pm |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
92,081 | $0 | $0 | 0 (Direct) |
View |
| 2022-04-01 Purchase |
2022-04-04 4:15 pm |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
10,000 | $0.7474 | $7,474 | 52,081 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-29 Option Award |
2024-05-31 4:58 pm |
N/A 2034-05-29 |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 4:15 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
20,000 | $0 | 55,000 (Direct) |
View |
| 2023-10-05 Option Award |
2023-10-10 5:39 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
20,000 | $0 | 35,000 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 4:28 pm |
N/A 2033-05-09 |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 08:30 am |
N/A N/A |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
20,000 | $0.4591 | 427,081 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 08:30 am |
N/A 2032-05-31 |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
20,000 | $0 | 427,081 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 6:00 pm |
N/A 2033-02-28 |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
585,000 | $0 | 585,000 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 08:09 am |
N/A N/A |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
20,000 | $0.4591 | 427,081 (Direct) |
View |
| 2023-02-09 Exercise |
2023-02-13 08:09 am |
N/A 2032-05-31 |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
20,000 | $0 | 427,081 (Direct) |
View |
| 2022-10-04 Option Award |
2022-10-06 6:11 pm |
N/A 2028-02-06 |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
1,930,956 | $0 | 1,930,956 (Direct) |
View |
| 2022-09-15 Option Award |
2022-09-19 5:40 pm |
N/A N/A |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 08:00 am |
N/A 2032-05-31 |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
375,000 | $0 | 375,000 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-12 8:26 pm |
N/A 2032-05-10 |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2022-01-05 Option Award |
2022-01-07 5:09 pm |
N/A 2032-01-05 |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
2,214 | $9.03 | 2,214 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-18 4:55 pm |
N/A 2031-08-17 |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2021-05-12 Option Award |
2021-05-17 5:04 pm |
N/A 2031-05-12 |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
8,300 | $0 | 8,300 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:00 pm |
N/A 2031-01-31 |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
337,731 | $0 | 337,731 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-01 4:15 pm |
N/A 2028-02-06 |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
10,000 | $0 | 468,266 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-01 4:15 pm |
N/A N/A |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
10,000 | $2.44 | 468,266 (Direct) |
View |
| 2021-01-11 Tax Withholding |
2021-01-12 4:49 pm |
N/A N/A |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
3,706 | $6.72 | 32,081 (Direct) |
View |
| 2021-01-08 Option Award |
2021-01-12 4:49 pm |
N/A N/A |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
10,667 | $0 | 32,081 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:28 pm |
N/A 2031-01-04 |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
1,314 | $13.31 | 1,314 (Direct) |
View |
| 2020-10-27 Option Award |
2020-10-27 5:37 pm |
N/A 2030-10-27 |
Spero Therapeutics Inc. | SPRO | THOMAS FRANK E Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2020-09-29 Option Award |
2020-09-30 1:52 pm |
N/A 2030-07-16 |
Larimar Therapeutics Inc. | LRMR | THOMAS FRANK E Director |
16,600 | $0 | 16,600 (Direct) |
View |
| 2020-06-11 Exercise |
2020-06-15 5:03 pm |
N/A 2028-02-06 |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
10,000 | $0 | 461,305 (Direct) |
View |
| 2020-06-11 Exercise |
2020-06-15 5:03 pm |
N/A N/A |
Orchard Therapeutics plc | ORTX | THOMAS FRANK E See Remarks |
10,000 | $2.44 | 461,305 (Direct) |
View |